Medicine is capable of detecting cancer and identifying how cancers might resist treatment. Here are four things to know about the test: Read the full study here.

Researchers show that glycoRNAs, uncovered by the lab of Nobel Laureate, Carolyn Bertozzi, can be used to fight cancer.

Fred Hutch and MSK researchers showed that tumors driven by hiccups in RNA processing can't hid from the immune system. In ...

Creyon Bio, Inc. ("Creyon") today announced the appointment of industry leader, Serge Messerlian as Chief Executive Officer, ...

The Department of Health and Human Services, which oversees FDA and other health agencies, did not immediately respond to a ...

The Concerto™ System introduces a first-of-its-kind multiplexed, multi-omic digital detection platform, enabling real-time, high-plex quantification of DNA, RNA and protein biomarkers from a single ...

Long-acting injectable HIV treatment leads to rectal shedding in a small proportion of patients with HIV, independent of the ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

Bin Wu, associate professor in the department of Biophysics and Biophysical Chemistry at the School of Medicine, visited ...

In 2021, research led by Ryan Flynn, MD, Ph.D., and his mentor, Nobel laureate Carolyn Bertozzi, Ph.D., opened a new chapter ...

Letter, Bloomberg Distinguished Professor Jeff Coller discussed his research on the development of a new experimental protein ...

These insights from researchers could have major implications for diseases like cancer, where gene expression goes awry.